Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
PRGO Perrigo Company plc daily Stock Chart
PRGO [NYSE]
Perrigo Company plc
Healthcare | Drug Related Products | Ireland
financial highlights | statements
IndexS&P 500 P/E41.22 EPS (ttm)1.77 Insider Own0.10% Shs Outstand138.10M Perf Week4.38%
Market Cap10.08B Forward P/E13.64 EPS next Y5.35 Insider Trans267.38% Shs Float136.48M Perf Month-3.78%
Income249.80M PEG7.78 EPS next Q1.05 Inst Own85.70% Short Float5.67% Perf Quarter-4.26%
Sales4.92B P/S2.05 EPS this Y103.40% Inst Trans0.68% Short Ratio5.90 Perf Half Y-18.53%
Book/sh42.70 P/B1.71 EPS next Y9.48% ROA2.00% Target Price84.00 Perf Year-6.09%
Cash/sh3.83 P/C19.06 EPS next 5Y5.30% ROE3.90% 52W Range67.53 - 95.93 Perf YTD-16.29%
Dividend0.76 P/FCF20.74 EPS past 5Y-27.40% ROI3.30% 52W High-23.94% Beta0.86
Dividend %1.04% Quick Ratio1.20 Sales past 5Y6.90% Gross Margin40.10% 52W Low8.04% ATR2.10
Employees10400 Current Ratio1.80 Sales Q/Q-4.20% Oper. Margin11.60% RSI (14)44.25 Volatility2.91% 2.36%
OptionableYes Debt/Eq0.56 EPS Q/Q153.70% Profit Margin4.80% Rel Volume1.70 Prev Close70.40
ShortableYes LT Debt/Eq0.52 EarningsAug 09 BMO Payout42.00% Avg Volume1.31M Price72.96
Recom2.80 SMA20-3.53% SMA50-3.16% SMA200-10.76% Volume2,225,341 Change3.64%
Aug-10-18Reiterated Stifel Hold $92 → $87
Jul-30-18Downgrade Argus Buy → Hold
Jul-12-18Downgrade Goldman Neutral → Sell
Jan-03-18Initiated Leerink Partners Mkt Perform $90
Dec-08-17Upgrade Argus Hold → Buy
Nov-10-17Upgrade RBC Capital Mkts Underperform → Sector Perform $64 → $86
Oct-05-17Reiterated UBS Buy $84 → $98
Sep-07-17Initiated Oppenheimer Outperform $88
Aug-11-17Upgrade Goldman Sell → Neutral
Aug-11-17Reiterated RBC Capital Mkts Underperform $60 → $64
Jun-16-17Initiated Cantor Fitzgerald Overweight $85
Jun-05-17Downgrade RBC Capital Mkts Sector Perform → Underperform $66 → $60
Mar-03-17Reiterated B. Riley & Co. Neutral $83 → $67
Feb-28-17Reiterated Canaccord Genuity Buy $100 → $97
Feb-22-17Initiated Canaccord Genuity Buy $100
Jan-23-17Reiterated Jefferies Hold $84 → $70
Jan-17-17Reiterated RBC Capital Mkts Sector Perform $92 → $85
Nov-11-16Upgrade BofA/Merrill Underperform → Neutral
Nov-11-16Reiterated B. Riley & Co. Neutral $87 → $97
Aug-11-16Reiterated Barclays Overweight $120 → $110
Aug-10-18 11:11AM  Perrigo Needs 'Meet-Or-Beat' Quarters, Deutsche Bank Says In Downgrade Benzinga
Aug-09-18 07:46PM  [$$] Perrigo to Separate Its Prescription Pharmaceutical Business The Wall Street Journal -10.56%
05:57PM  Perrigo Company plc -- Moody's says Perrigo's ratings unaffected following announced separation of prescription business Moody's
05:06PM  [$$] Perrigo to Separate Its Prescription Pharmaceutical Business The Wall Street Journal
02:46PM  Mylan, Perrigo Earnings: Look Out Below! Barrons.com
02:08PM  Generic Drugmakers Struggle Despite U.S. Push for Copycats Bloomberg
10:35AM  Perrigo plans to separate prescription pharma business Reuters
09:48AM  Perrigo (PRGO) Beats on Q2 Earnings, Cuts View, Shares Down Zacks
08:48AM  Perrigo stock drops 6.5% after Q2 revenue miss, guidance cuts; company plans to separate drug unit MarketWatch
07:54AM  Stocks making the biggest moves premarket: VIAB, TRCO, BKNG, PRTY & more CNBC
07:30AM  Perrigo (PRGO) Beats Q2 Earnings Estimates Zacks
06:30AM  Perrigo Co. Plc to Host Earnings Call ACCESSWIRE
05:02AM  Perrigo: 2Q Earnings Snapshot Associated Press
12:11AM  Perrigo Expands OTC Growth Strategy With Rx-To-OTC Switch Licensing For Nasonex® PR Newswire
12:07AM  Perrigo Announces Plan To Separate Prescription Pharmaceuticals Business PR Newswire
12:02AM  Perrigo Company plc Reports Second Quarter 2018 Financial Results PR Newswire
Aug-08-18 03:05PM  Perrigo's Q2 Earnings Preview Benzinga
09:18AM  Drug/Biotech Stock Q2 Earnings on Aug 9: PRGO, BDSI & More Zacks
08:41AM  What's in the Cards for Perrigo (PRGO) This Earnings Season? Zacks
Aug-01-18 08:44AM  Perrigo Announces Quarterly Dividend PR Newswire
Jul-26-18 08:23AM  Perrigo To Release Second Quarter Calendar Year 2018 Financial Results On August 9, 2018 PR Newswire
Jul-24-18 07:35AM  Complimentary Technical Snapshots on Aquinox Pharma and Three More Healthcare Stocks ACCESSWIRE
Jul-17-18 05:12PM  After the Bell: Dow Rises 56 Points as Stocks Keep Chugging Higher Barrons.com
Jul-12-18 03:21PM  Drug Makers Can't Cure Investor Impatience Barrons.com
10:28AM  Goldman Sachs Swaps Perrigo, Johnson & Johnson Ratings Benzinga
Jun-29-18 09:37PM  AbbVie, AndroGel partner owe $448 million in antitrust case -U.S. judge Reuters
Jun-25-18 11:07AM  Conviction of SAC's Martoma upheld despite jury instructions Reuters
Jun-22-18 01:52PM  Should You Buy Perrigo Company plc (NYSE:PRGO) Based On These Aspects? Simply Wall St.
Jun-08-18 01:19PM  Valeant Pharmaceuticals Intl Inc Has New Name But Same Problems InvestorPlace
Jun-06-18 11:41AM  Valeant & Perrigo: Buy One, Skip the Other Barrons.com
07:55AM  Report: Developing Opportunities within Silicon Motion Technology, Green Brick Partners, Alliance Resource Partners, Perrigo Company plc, Epizyme, and Landec Future Expectations, Projections Moving into 2018 GlobeNewswire
Jun-01-18 02:23PM  Perrigo Stock Is Just Bearish, Any Way You Look At It TheStreet.com
07:30AM  Breakfast Technical Briefing on Johnson & Johnson and Three Other Additional Healthcare Stocks ACCESSWIRE
May-30-18 08:30AM  Perrigo to Present at the Jefferies 2018 Healthcare Conference PR Newswire
May-24-18 08:35AM  Perrigo Confirms Patent Challenge For Generic Version Of Sernivo® Spray, 0.05% PR Newswire
May-21-18 01:42PM  Starboard Value Buys $30.2 Million More in Perrigo Stock Barrons.com
May-20-18 04:21PM  Benzinga's Insider Buys Of The Week: JPMorgan, Philip Morris And More Benzinga
May-17-18 04:35PM  Is There An Opportunity With Perrigo Company plcs (NYSE:PRGO) 30% Undervaluation? Simply Wall St.
May-16-18 07:29AM  Aspen's Infant Formula Unit Is Said to Draw Reckitt, Perrigo Bloomberg
May-14-18 04:55PM  Teva Pharma Spiked To Perrigo's Detriment On Asthma Inhaler Delay Investor's Business Daily
09:25AM  Perrigo Confirms First To File Patent Challenge For Generic Version Of Ultravate® Lotion, 0.05% PR Newswire
09:24AM  Stocks to Watch: Tesla, Alphabet, Xerox, Sears, Qualcomm, NXP, Walmart, JPMorgan, Ford, HP The Wall Street Journal
09:11AM  Morning Movers: Qualcomm, NXP Jump as China Restarts Merger Review, Perrigo Drops on Drug Review Barrons.com
May-11-18 05:07PM  Perrigo Drops After Saying FDA to Reject Inhaler, Delaying Start Bloomberg
05:02PM  [$$] FDA Rejects Perrigo's ProAir Generic, Drug Maker Says The Wall Street Journal
04:32PM  Perrigo no longer expects to get approval for generic Pro... CNBC Videos
04:30PM  Perrigo shares falls after company trims 2018 outlook MarketWatch
04:01PM  Perrigo Expects Complete Response Letter On Generic Version Of ProAir® PR Newswire
May-10-18 02:06PM  Edited Transcript of PRGO earnings conference call or presentation 8-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-08-18 03:52PM  Perrigo (PRGO) Misses on Earnings in Q1, Reiterates View Zacks
10:43AM  Valeant Upside, Shire Buyout Don't Rally Pharma Stocks Barrons.com
12:01AM  Perrigo Company plc Reports First Quarter 2018 Financial Results PR Newswire
May-03-18 09:41AM  Perrigo Announces Quarterly Dividend PR Newswire
May-02-18 11:28AM  Is a Beat in the Cards for Perrigo (PRGO) in Q1 Earnings? Zacks
Apr-27-18 06:50PM  Amneal And Impax Receive FTC Clearance For Business Combination PR Newswire
05:27PM  Amneal, Impax win U.S. deal approval with conditions Reuters
05:11PM  U.S. FTC requires Amneal and Impax to divest rights to 10 generic drugs Reuters
Apr-24-18 04:58PM  Generic drugmakers to face first charges in U.S. probe - Bbg Reuters
Apr-13-18 07:00AM  Free Post Earnings Research Report: Perrigo Co.'s Quarterly Earnings Increased 3.23% ACCESSWIRE
Apr-11-18 09:41AM  Perrigo Launches Novel Omeprazole Orally Disintegrating Tablet to Treat Frequent Heartburn PR Newswire
Apr-06-18 07:33AM  Impax Launches a Generic Version of Estrace® Cream (estradiol vaginal cream, USP, 0.01%) PR Newswire
Apr-04-18 12:07PM  Is Perrigo Company plc (NYSE:PRGO) A Sell At Its Current PE Ratio? Simply Wall St.
Apr-02-18 02:54AM  Why Is Perrigo Company (PRGO) Up 4.7% Since Its Last Earnings Report? Zacks
Mar-29-18 11:39AM  A Detailed Review Of Starboard Value's Stock Portfolio Benzinga
Mar-26-18 07:05AM  Sol-Gel Technologies Reports Fourth Quarter and Full Year 2017 Financial Results GlobeNewswire
Mar-23-18 01:48PM  Will Perrigo Company plc (NYSE:PRGO) Continue To Underperform Its Industry? Simply Wall St.
Mar-07-18 08:49AM  Perrigo Announces Final FDA Approval and Planned Launch for the Store Brand OTC Equivalent of Mucinex® DM Maximum Strength Extended Release Tablets PR Newswire
08:46AM  Perrigo to Present at Upcoming Investor Conferences PR Newswire
03:54AM  Edited Transcript of PRGO earnings conference call or presentation 2-Mar-18 1:30pm GMT Thomson Reuters StreetEvents
Mar-02-18 04:16PM  Perrigo shares rise more than 4%, snapping losing streak MarketWatch
12:12PM  Perrigo (PRGO) Surpassed Earnings in Q4, Revenues Down Y/Y Zacks
Mar-01-18 05:06PM  Perrigo Files Form 10-K With SEC; Will Host Fourth Quarter And Calendar Year 2017 Financial Results Conference Call On March 2, 2018 PR Newswire
05:04PM  Perrigo Company plc Reports Fourth Quarter & Calendar Year 2017 Financial Results PR Newswire
Feb-27-18 09:53AM  Perrigo (PRGO) Postpones Q4 Earnings Results, Shares Down Zacks -7.13%
01:07AM  Perrigo Company plc Reports Select Preliminary Unaudited Calendar Year 2017 Financial Results PR Newswire
Feb-26-18 07:45AM  Perrigo Co. Plc to Host Earnings Call ACCESSWIRE
Feb-25-18 03:53PM  Is Perrigo Company plcs (NYSE:PRGO) Balance Sheet A Threat To Its Future? Simply Wall St.
Feb-21-18 10:36AM  Is a Beat in the Cards for Perrigo (PRGO) in Q4 Earnings? Zacks
Feb-20-18 11:33PM  Trial Tests FTCs Power to Referee Drug Makers Fight Against Generics The Wall Street Journal
03:14PM  Amazon has quietly launched an exclusive line of over-the-counter health products CNBC
08:34AM  Perrigo shares decline 1% on news of Bayer lawsuit over generic rosacea product MarketWatch
08:17AM  Perrigo Confirms Patent Challenge For Generic Version Of Finacea® Foam, 15% PR Newswire
08:00AM  Trial Tests FTC's Power to Referee Drugmakers' Fight Against Generics The Wall Street Journal
08:00AM  Perrigo Appoints Ronald L. Winowiecki as Chief Financial Officer PR Newswire
Feb-19-18 05:51PM  Does Perrigo Company plcs (NYSE:PRGO) Past Performance Indicate A Stronger Future? Simply Wall St.
Feb-15-18 09:17AM  Perrigo Announces Quarterly Dividend PR Newswire
Feb-08-18 08:14AM  Perrigo To Release Fourth Quarter And Calendar Year 2017 Financial Results On February 27, 2018 PR Newswire
Jan-30-18 02:01PM  NYSE trader: UnitedHealth and other oligopolies just got Amazon'd Yahoo Finance Video
08:17AM  Perrigo Announces Tentative FDA Approval For The Generic Version Of Soolantra® Cream, 1% PR Newswire
Jan-26-18 12:53PM  Perrigo Announces Tentative FDA Approval For The Generic Version Of Onexton® Gel PR Newswire
07:10AM  Blog Exposure - FDA Granted Final Approval to a Generic Version of Perrigos Estrace Cream ACCESSWIRE
Jan-25-18 05:35PM  GlaxoSmithKline Could Witness Modest Rise in Revenues in 2017 Market Realist
04:04PM  What Analysts Recommend for GlaxoSmithKline in January 2018 Market Realist
11:10AM  Pfizer: Revenue Growth Is Expected in 4Q17 Market Realist
Jan-24-18 07:51AM  Perrigo Announces Final FDA Approval Of A Generic Version Of Estrace® Cream PR Newswire
07:46AM  Perrigo Announces Final FDA Approval And Launch Of An AB Rated Generic Version Of Epiduo® Gel PR Newswire
Jan-16-18 08:06AM  See what the IHS Markit Score report has to say about Perrigo Company PLC. Markit
Jan-12-18 10:05AM  Perrigo (PRGO) Hits 52-Week High: What's Driving the Stock? Zacks
Jan-11-18 12:58PM  Is Valeant Pharmaceuticals Intl Inc a Buy? 3 Pros, 3 Cons InvestorPlace
10:32AM  Recent Developments for Mylan Market Realist
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments. It offers OTC products in cough, cold, allergy, sinus, analgesic, gastrointestinal, smoking cessation, infant formula and food, animal health, diagnostic, lifestyle, personal care and derma-therapeutics, natural health and vitamins, and anti-parasite categories. The company also develops, manufactures, and markets a portfolio of generic prescription drugs, such as creams, ointments, lotions, gels, shampoos, foams, suppositories, sprays, liquids, suspensions, solutions, powders, controlled substances, injectables, hormones, oral solid dosage forms, and oral liquid formulations. In addition, it offers contract manufacturing services. The company offers its products through retail drug, supermarket, and mass merchandise chains; hospitals; pharmacies; wholesalers; drug and grocery stores; and para pharmacies, as well as through a network of pharmacy sales force in North America, Europe, Australia, Israel, and China. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Andersen SvendEVP & President CHCIAug 14Buy69.437,200499,8967,200Aug 16 03:30 PM
Winowiecki RonaldCFOJul 23Option Exercise75.972,297174,5036,320Jul 24 01:36 PM
Weninger PaulEVP, Quality OperationsJun 29Option Exercise72.9173253,3704,486Jul 03 07:51 PM
Quinn GrainneEVP, Chief Medical OfficerJun 29Option Exercise72.9126219,1022,533Jul 03 07:49 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainJun 29Option Exercise72.9182760,2972,562Jul 03 07:38 PM
Winowiecki RonaldCFOJun 29Option Exercise72.9181859,6404,257Jul 03 07:34 PM
Wesolowski JohnEVP, President RxJun 29Option Exercise72.9148135,0702,113Jul 03 07:30 PM
Samuels Theodore R. IIDirectorJun 06Option Exercise73.224,265312,2835,624Jun 08 05:22 PM
KINDLER JEFFREY BDirectorJun 06Option Exercise73.224,265312,2834,793Jun 08 05:20 PM
Parker Geoffrey M.DirectorJun 06Option Exercise73.224,265312,2835,277Jun 08 05:19 PM
Alford Bradley ADirectorJun 06Option Exercise73.224,265312,2834,796Jun 08 05:17 PM
CLASSON ROLF ADirectorJun 06Option Exercise73.224,265312,2834,265Jun 08 05:14 PM
Smith Jeffrey CDirectorJun 06Option Exercise73.224,265312,2834,793Jun 08 05:12 PM
BRLAS LAURIEDirectorJun 06Option Exercise73.225,331390,33617,888Jun 08 05:10 PM
COHEN GARY MDirectorJun 06Option Exercise73.224,265312,28319,312Jun 08 05:09 PM
Karaboutis AdrianaDirectorJun 06Option Exercise73.224,265312,2834,265Jun 08 05:08 PM
O'Connor DonalDirectorJun 06Option Exercise73.224,265312,2837,443Jun 08 05:05 PM
Smith Jeffrey CDirectorMay 17Buy75.8950,0003,794,6453,662,220May 17 09:03 PM
Smith Jeffrey CDirectorMay 16Buy75.83100,0007,582,6103,616,273May 17 09:03 PM
Smith Jeffrey CDirectorMay 15Buy75.21250,00018,802,0133,526,419May 17 09:03 PM
Roehrhoff UweCEOMar 05Buy81.857,500613,8637,500Mar 07 04:46 PM
Winowiecki RonaldInterim CFOMar 01Option Exercise79.571,776141,3163,957Mar 05 03:17 PM
Wesolowski JohnEVP, President RxMar 01Option Exercise79.571,03382,1961,963Mar 05 03:12 PM
KINGMA TODD WExecutive VP, General CounselDec 28Option Exercise87.272,571224,37119,565Dec 29 11:45 AM
KINGMA TODD WExecutive VP, General CounselDec 28Sale88.521,500132,78017,252Dec 29 11:45 AM
Winowiecki RonaldInterim CFODec 22Option Exercise87.0184673,6102,449Dec 27 04:35 PM
Wesolowski JohnEVP, President RxDec 15Option Exercise86.5032428,0261,033Dec 19 06:45 PM
Wesolowski JohnEVP, President RxDec 14Buy85.8070060,060709Dec 19 06:54 PM
Wesolowski JohnEVP, President RxDec 07Sale83.0945037,3909Dec 11 08:30 PM
Wesolowski JohnEVP, President RxNov 29Sale87.6516814,72580Nov 30 06:28 PM
Wesolowski JohnEVP, President RxNov 28Sale86.8622019,109248Nov 30 06:28 PM
Farrington ThomasEVP and CIONov 16Sale87.2621318,5852,937Nov 20 02:53 PM
HENDRICKSON JOHN TCEONov 03Option Exercise82.362,181179,6279,164Dec 14 06:48 PM
Farrington ThomasEVP and CIONov 03Option Exercise82.3662351,3103,347Nov 20 02:53 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainSep 12Sale88.7126123,1541,616Sep 14 07:18 PM
Needham JeffreyEVP, President CHC AmericasSep 12Sale89.493,595321,7079,718Sep 14 07:13 PM
Kochan SharonEVP, GM InternationalSep 07Sale81.3631825,87410,031Sep 11 04:56 PM
Wesolowski JohnEVP, President RxSep 07Sale82.3920216,620847Dec 19 06:52 PM
Kochan SharonEVP, GM InternationalAug 31Sale79.031,500118,54510,349Sep 05 02:33 PM
Farrington ThomasEVP and CIOAug 30Sale76.9061647,3702,724Sep 01 12:13 PM
Winowiecki RonaldInterim CFOAug 21Option Exercise77.5822717,6111,411Aug 23 08:25 PM
HENDRICKSON JOHN TCEOAug 21Option Exercise77.581,316102,0956,211Aug 23 08:23 PM
Weninger PaulEVP, Quality OperationsAug 21Option Exercise77.5816813,0332,337Aug 23 08:21 PM
Quinn GrainneEVP, Chief Medical OfficerAug 21Option Exercise77.5814711,4042,227Aug 23 08:19 PM
Farrington ThomasEVP and CIOAug 21Option Exercise77.5866851,8232,773Aug 23 08:16 PM
KINGMA TODD WExecutive VP, General CounselAug 21Option Exercise77.581,316102,09515,876Aug 23 08:13 PM
Needham JeffreyEVP, President CHC AmericasAug 21Option Exercise77.581,11386,34712,369Aug 23 08:11 PM
Kochan SharonEVP, GM InternationalAug 21Option Exercise77.581,11386,34710,707Aug 23 08:08 PM
Janish Ronald CraigEVP, Global Op. & Supply ChainAug 21Option Exercise77.5825820,0161,732Aug 23 08:04 PM
Wesolowski JohnEVP, President RxAug 21Option Exercise77.5813410,396356Aug 23 07:59 PM
open in yahoo | open in reuters | open in google